Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

European Journal of Surgical Oncology

Volumn 40, Issue 1, 2014, Pages 12-26

  Coccolini, F ^a,b   Cotte, E ^b   Glehen, O ^b   Lotti, M ^a   Poiasina, E ^a   Catena, F ^c   Yonemura, Y ^d   Ansaloni, L ^a  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b UNIVERSITÉ LYON 1   (France)

^c MAGGIORE HOSPITAL   (Italy)

^d Kusatsu General Hospital   (Japan)

Author keywords

Carcinosis; Gastric cancer; HIPEC; Intraperitoneal chemotherapy; Meta analysis; Nodal infiltration

Indexed keywords

ACTIVATED CARBON; CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; DISTANT METASTASIS; FOLLOW UP; HEMATOGENOUS METASTASIS; HUMAN; INTENTION TO TREAT ANALYSIS; INTRAPERITONEAL HYPERTHERMIC CHEMOPERFUSION; LYMPH NODE METASTASIS; META ANALYSIS; METASTASIS; MORBIDITY; OVERALL SURVIVAL; PERITONEUM METASTASIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROSAL INFILTRATION; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR INVASION;

CARCINOSIS; GASTRIC CANCER; HIPEC; INTRAPERITONEAL CHEMOTHERAPY; META-ANALYSIS; NODAL INFILTRATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL CAVITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84892531071     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.10.019     Document Type: Review

References (48)

1. J.R. Kelley, and J.M. Duggan Gastric cancer epidemiology and risk factors J Clin Epidemiol 56 1 2003 1 9
2. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J Clin 49 1 1999 33 64
3. K. Nakamura, T. Ueyama, and T. Yao et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy Cancer 70 1992 1030 1037
4. T. Takahashi, A. Hagiwara, K. Sawai, S. Kondo, and T. Yamaguchi Intensive intraoperative local chemotherapy for lymph node and peritoneal metastases in gastric cancer Onkologie 14 1991 152 157
5. C.C. Yu, D.A. Levison, and J.A. Dunn et al. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer Br J Cancer 71 1995 1106 1110
6. M. Ikeguchi, A. Oka, S. Tsujitani, M. Maeta, and N. Kaibara Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer Anticancer Res 14 1994 2131 2134
7. M. Kuramoto, S. Shimada, and S. Ikeshima et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma Ann Surg 250 2009 242 246
8. L.L. Gunderson, and H. Sosin Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phys 8 1982 1 11
9. R. Hamazoe, M. Maeta, and N. Kaibara Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study Cancer 73 1994 2048 2052
10. M. Ikeguchi, A. Kondou, A. Oka, S. Tsujitani, M. Maeta, and N. Kaibara Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion Eur J Surg 161 1995 581 586
11. S. Koga, R. Hamazoe, M. Maeta, N. Shimizu, A. Murakami, and T. Wakatsuki Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C Cancer 61 1988 232 237
12. A.D. Wagner, S. Unverzagt, and W. Grothe et al. Chemotherapy for advanced gastric cancer Cochrane Database Syst Rev 3 2010 Mar 17 CD004064
13. E. Van Cutsem, V.M. Moiseyenko, and S. Tjulandin et al. V325 study group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group J Clin Oncol 24 2006 4991 4997
14. D. Cunningham, N. Starling, and S. Rao et al. Upper gastrointestinal clinical studies group of the national cancer research institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 2008 36 46
15. A.D. Roth, N. Fazio, and R. Stupp et al. Swiss group for clinical cancer research. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss group for clinical cancer research J Clin Oncol 25 2007 3217 3223
16. P. Ross, M. Nicolson, and D. Cunningham et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer J Clin Oncol 20 2002 1996 2004
17. H. Baba, M. Yamamoto, and K. Endo et al. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer Gastric Cancer 6 Suppl. 1 2003 45 49
18. H. Yabusaki, A. Nashimoto, and O. Tanaka Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer Gan To Kagaku Ryoho 30 2003 1933 1940
19. P. Preusser, H. Wilke, and W. Achterrath et al. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer J Clin Oncol 7 1989 1310 1317
20. H.A. Al-Shammaa, Y. Li, and Y. Yonemura Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis World J Gastroenterol 14 2008 11
21. T.D. Yan, D. Black, and P.H. Sugarbaker et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 2007 2702 2713
22. J.L. Speyer, P.H. Sugarbaker, and J.M. Collins et al. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans Cancer Res 41 1981 1916 1922
23. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions: the cochrane collaboration 2008 John Wiley & Sons Chirchester (UK)
24. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
25. D.L. Demets Methods for combining randomized clinical trials: strengths and limitations Stat Med 6 3 1987 341 350
26. A. Hagiwara, T. Takahashi, and O. Kojima et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer Lancet 339 1992 629 631
27. T. Sautner, F. Hofbauer, D. Depisch, R. Schiessel, and R. Jakesz Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer J Clin Oncol 12 5 1994 970 974
28. T. Fujimura, Y. Yonemura, and K. Muraoka et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study World J Surg 18 1 1994 150 155
29. T. Takahashi, A. Hagiwara, M. Shimotsuma, K. Sawai, and T. Yamaguchi Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles World J Surg 19 4 1995 565 569
30. S. Fujimoto, M. Takahashi, T. Mutou, K. Kobayashi, and T. Toyosawa Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma Cancer 85 3 1999 529 534
31. H.R. Rosen, G. Jatzko, and S. Repse et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology J Clin Oncol 16 8 1998 2733 2738
32. W. Yu, I. Whang, H.Y. Chung, A. Averbach, and P.H. Sugarbaker Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial World J Surg 25 8 2001 985 990
33. S. Shimoyama, N. Shimizu, and M. Kaminishi Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer World J Surg 23 3 1999 284 291
34. Y. Yonemura, X. de Aretxabala, and T. Fujimura et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study Hepatogastroenterology 48 42 2001 1776 1782
35. G. Wei, G.E. Fang, and J.W. Bi et al. Efficacy of intraoperative hypothonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer Chinese J Cancer 24 4 2005 478 482
36. X.J. Yang, C.Q. Huang, and T. Suo et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial Ann Surg Oncol 18 6 2011 1575 1581
37. I. Miyashiro, H. Furukawa, M. Sasako Gastric Cancer Surgical Study Group in the Japan Clinical Oncology Group Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2 Gastric Cancer 14 3 2011 212 218
38. W.T. Ding, D.M. Duan, G.S. Sun, and C. Gu Clinical observation on early intraperitoneal hypothermic perfusion chemotherapy in the treatment of stomach carcinoma after operation Tumor 27 7 2007 585 587
39. H.J. Deng, Z.G. Wei, L. Zhen, G.X. Li, X.C. Huang, and S.H. Quing Clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer J South Med Univ 29 2 2009 295 297
40. Y. Zuo, M. Xu, D. Shen, W.D. Lu, and J.F. Lu Postoperative intraperitoneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients Chin J Oncol 26 4 2004 247 249
41. C.Q. Tan, X.J. Wang, and Y.K. Xu Clinical studies on prevention of post-operational intraperitoneal neoplasm seeding of advanced gastric cancer by surgery combined with intraperitoneal perfusion of hyperthermic mitomycin C J Pract Oncol 15 3 2000 165 167
42. O. Glehen, F.N. Gilly, C. Arvieux Association Française de Chirurgie Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy Ann Surg Oncol 17 9 2010 2370 2377
43. Y. Yonemura, A. Elnemr, and Y. Endou et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer World J Gastrointest Oncol 2 2 2010 Feb 15 85 97
44. European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group Gastric cancer in Europe Br J Surg 95 2008 406 408
45. D.Z. Xu, Y.Q. Zhan, X.W. Sun, S.M. Cao, and Q.R. Geng Meta-analysis of intraperitoneal chemotherapy for gastric cancer World J Gastroenterol 10 18 2004 2727 2730
46. J.Y. Huang, Y.Y. Xu, and Z. Sun et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis Asian Pac J Cancer Prev 13 9 2012 4379 4385
47. J. Sun, Y. Song, and Z. Wang et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials BMC Cancer 12 2012 526
48. D.H. Mi, Z. Li, and K.H. Yang et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials Int J Hyperthermia 29 2 2013 156 167